Skip Navigation
SummeRun
Your generosity is vital
Generous gifts from individuals, corporations, and foundation donors account for nearly all of the Rivkin Center’s revenue. By supporting the Rivkin Center, you contribute directly to the advancement of knowledge in the prevention, early detection, and improved treatment of ovarian cancer.

You help us fund ovarian cancer research

Since the Rivkin Center was established in 1996, we’ve awarded over $9 million in grants, making us one of the largest private funders of ovarian cancer research in the United States. Our international grant-making program is overseen by our Scientific Advisory Board, a prestigious roster of the best and brightest minds in the field. Rivkin-funded scientists go on to make an important impact. A snapshot of 80 Awards made from 2008 to 2013 showed that:
  • Of the 78.1% of past Rivkin Center grant awardees who have applied for continuing grants from other institutions, more than half have been successful at receiving funding to extend their research
  • This translates to over $33 million in new grants from other institutions from a $4.7 million investment by the Rivkin Center – over a 7.2-fold return on investment!
  • 55% of publications authored by past Rivkin grant award recipients have been published in top scientific research journals

You help support our research symposium

Your gifts to the Rivkin Center also support the biennial Ovarian Cancer Research Symposium. Established by the Rivkin Center in Seattle in 1994, the Symposium is now the longest-running meeting of its kind in the U.S. In 2014, a record-breaking 370 researchers traveled from all over the globe to share their findings and ideas on ovarian cancer biology, prevention, early detection, and therapies. In addition to the 39 outstanding speakers on the agenda, attendees filled the two days of the event with conversations, mentoring sessions, collaboration, and networking. The next Symposium will take place in September 2016 at the University of Washington in Seattle and will be co-presented by the American Association for Cancer Research (AACR), the nation’s largest cancer research professional society.

You help support advances in early detection

The Rivkin Center established the Ovarian Cancer Early Detection Program, an important surveillance program for women at high risk of developing ovarian cancer. The program, based in the Wanda Jankelson Ovarian Cancer Screening Clinic at Swedish Medical Center in Seattle, has provided free screening to more than 500 women consenting to participate.

Annual report

Each year, with the generous support of individual and corporate donors we are delighted by the continued success and growth of the Rivkin Center for Ovarian Cancer. Our 2015 Annual Report to the Community highlights the achievements of our research programs and includes our annual donor listing and financial statement.

Download our Annual Reports (PDF).

The Rivkin Center has invested over $9 million in research grants.
The Rivkin Center has invested $4.7 million in ovarian cancer research grants
This investment translates to $33 million in new grants from other institutions
This has resulted in over a 7.2-fold return on investment for the Rivkin Center